These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25861236)

  • 1. Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC Following Chemotherapy.
    Kumon H; Sasaki K; Ariyoshi Y; Sadahira T; Ebara S; Hiraki T; Kanazawa S; Yanai H; Watanabe M; Nasu Y
    Clin Med Insights Oncol; 2015; 9():31-8. PubMed ID: 25861236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The induction of antigen-specific CTL by in situ Ad-REIC gene therapy.
    Ariyoshi Y; Watanabe M; Eikawa S; Yamazaki C; Sadahira T; Hirata T; Araki M; Ebara S; Nasu Y; Udono H; Kumon H
    Gene Ther; 2016 May; 23(5):408-14. PubMed ID: 26836118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated REIC/Dkk-3 gene therapy: Development of an autologous cancer vaccination therapy (Review).
    Watanabe M; Nasu Y; Kumon H
    Oncol Lett; 2014 Mar; 7(3):595-601. PubMed ID: 24527065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising Gene Therapy Using an Adenovirus Vector Carrying REIC/Dkk-3 Gene for the Treatment of Biliary Cancer.
    Tanaka E; Uchida D; Shiraha H; Kato H; Ohyama A; Iwamuro M; Watanabe M; Kumon H; Okada H
    Curr Gene Ther; 2020; 20(1):64-70. PubMed ID: 32148193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated REIC/Dkk-3 gene transfer inhibits tumor growth and metastasis in an orthotopic prostate cancer model.
    Edamura K; Nasu Y; Takaishi M; Kobayashi T; Abarzua F; Sakaguchi M; Kashiwakura Y; Ebara S; Saika T; Watanabe M; Huh NH; Kumon H
    Cancer Gene Ther; 2007 Sep; 14(9):765-72. PubMed ID: 17599093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of Neoadjuvant Ad-REIC Gene Therapy in Patients with High-Risk Localized Prostate Cancer Undergoing Radical Prostatectomy.
    Kumon H; Sasaki K; Ariyoshi Y; Sadahira T; Araki M; Ebara S; Yanai H; Watanabe M; Nasu Y
    Clin Transl Sci; 2015 Dec; 8(6):837-40. PubMed ID: 26621187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of BiP/GRP78 sensitizes resistant prostate cancer cells to gene-therapeutic overexpression of REIC/Dkk-3.
    Tanimoto R; Sakaguchi M; Abarzua F; Kataoka K; Kurose K; Murata H; Nasu Y; Kumon H; Huh NH
    Int J Cancer; 2010 Apr; 126(7):1562-9. PubMed ID: 19626590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer.
    Hirata T; Watanabe M; Kaku H; Kobayashi Y; Yamada H; Sakaguchi M; Takei K; Huh NH; Nasu Y; Kumon H
    Int J Oncol; 2012 Aug; 41(2):559-64. PubMed ID: 22665039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel extracellular role of REIC/Dkk-3 protein in PD-L1 regulation in cancer cells.
    Gohara Y; Tomonobu N; Kinoshita R; Futami J; Audebert L; Chen Y; Komalasari NLGY; Jiang F; Yoshizawa C; Murata H; Yamamoto KI; Watanabe M; Kumon H; Sakaguchi M
    J Mol Med (Berl); 2023 Apr; 101(4):431-447. PubMed ID: 36869893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical biodistribution and safety study of reduced expression in immortalized cells/Dickkopf-3-encoding adenoviral vector for prostate cancer gene therapy.
    Sugimoto M; Watanabe M; Kaku H; Li SA; Noguchi H; Ueki H; Sakaguchi M; Huh NH; Nasu Y; Kumon H
    Oncol Rep; 2012 Nov; 28(5):1645-52. PubMed ID: 22941469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma.
    Shimazu Y; Kurozumi K; Ichikawa T; Fujii K; Onishi M; Ishida J; Oka T; Watanabe M; Nasu Y; Kumon H; Date I
    Gene Ther; 2015 Feb; 22(2):146-54. PubMed ID: 25394252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cysteine-rich core domain of REIC/Dkk-3 is critical for its effect on monocyte differentiation and tumor regression.
    Kinoshita R; Watanabe M; Huang P; Li SA; Sakaguchi M; Kumon H; Futami J
    Oncol Rep; 2015 Jun; 33(6):2908-14. PubMed ID: 25823913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma.
    Sawahara H; Shiraha H; Uchida D; Kato H; Kato R; Oyama A; Nagahara T; Iwamuro M; Horiguchi S; Tsutsumi K; Mandai M; Mimura T; Wada N; Takeuchi Y; Kuwaki K; Onishi H; Nakamura S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Yagi T; Nasu Y; Kumon H; Okada H
    J Gastroenterol Hepatol; 2017 Oct; 32(10):1769-1777. PubMed ID: 28168749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A super gene expression system enhances the anti-glioma effects of adenovirus-mediated REIC/Dkk-3 gene therapy.
    Oka T; Kurozumi K; Shimazu Y; Ichikawa T; Ishida J; Otani Y; Shimizu T; Tomita Y; Sakaguchi M; Watanabe M; Nasu Y; Kumon H; Date I
    Sci Rep; 2016 Sep; 6():33319. PubMed ID: 27625116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel REIC/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer.
    Sawahara H; Shiraha H; Uchida D; Kato H; Nagahara T; Iwamuro M; Kataoka J; Horiguchi S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Nasu Y; Kumon H; Okada H
    Cancer Gene Ther; 2016 Aug; 23(8):278-83. PubMed ID: 27468808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraperitoneal administration of an adenovirus vector carrying REIC/Dkk-3 suppresses peritoneal dissemination of scirrhous gastric carcinoma.
    Than SS; Kataoka K; Sakaguchi M; Murata H; Abarzua F; Taketa C; Du G; Yashiro M; Yanagihara K; Nasu Y; Kumon H; Huh NH
    Oncol Rep; 2011 Apr; 25(4):989-95. PubMed ID: 21249317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase.
    Abarzua F; Sakaguchi M; Takaishi M; Nasu Y; Kurose K; Ebara S; Miyazaki M; Namba M; Kumon H; Huh NH
    Cancer Res; 2005 Nov; 65(21):9617-22. PubMed ID: 16266978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
    Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
    Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial sensitization of human bladder cancer cells to a gene-therapeutic adenovirus carrying REIC/Dkk-3 by downregulation of BRPK/PINK1.
    Jin Y; Murata H; Sakaguchi M; Kataoka K; Watanabe M; Nasu Y; Kumon H; Huh NH
    Oncol Rep; 2012 Mar; 27(3):695-9. PubMed ID: 22076283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tumor suppressor REIC/Dkk-3 by a newly improved adenovirus vector with insertion of a hTERT promoter at the 3'-side of the transgene.
    Putranto EW; Kinoshita R; Watanabe M; Sadahira T; Murata H; Yamamoto KI; Futami J; Kataoka K; Inoue Y; Winarsa Ruma IM; Sumardika IW; Youyi C; Kubo M; Sakaguchi Y; Saito K; Nasu Y; Kumon H; Huh NH; Sakaguchi M
    Oncol Lett; 2017 Jul; 14(1):1041-1048. PubMed ID: 28693271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.